Henry Schein EBITDA 2012-2026 | HSIC
Henry Schein annual and quarterly EBITDA history from 2012 to 2026. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
- Henry Schein EBITDA for the quarter ending June 30, 2026 was $255M, a 12.33% increase year-over-year.
- Henry Schein EBITDA for the twelve months ending June 30, 2026 was $1.006B, a 5.89% increase year-over-year.
- Henry Schein 2025 annual EBITDA was $0.964B, a 3.66% increase from 2024.
- Henry Schein 2024 annual EBITDA was $0.93B, a 4.49% increase from 2023.
- Henry Schein 2023 annual EBITDA was $0.89B, a 7.19% decline from 2022.
|
Henry Schein Annual EBITDA (Millions of US $) |
|
|---|---|
| 2025 | $964 |
| 2024 | $930 |
| 2023 | $890 |
| 2022 | $959 |
| 2021 | $1,062 |
| 2020 | $721 |
| 2019 | $903 |
| 2018 | $744 |
| 2017 | $804 |
| 2016 | $941 |
| 2015 | $893 |
| 2014 | $867 |
| 2013 | $811 |
| 2012 | $744 |
| 2011 | $698 |
|
Henry Schein Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2026-06-30 | $255 |
| 2026-03-31 | $263 |
| 2025-12-31 | $245 |
| 2025-09-30 | $243 |
| 2025-06-30 | $227 |
| 2025-03-31 | $249 |
| 2024-12-31 | $243 |
| 2024-09-30 | $231 |
| 2024-06-30 | $233 |
| 2024-03-31 | $223 |
| 2023-12-31 | $134 |
| 2023-09-30 | $269 |
| 2023-06-30 | $260 |
| 2023-03-31 | $227 |
| 2022-12-31 | $124 |
| 2022-09-30 | $263 |
| 2022-06-30 | $273 |
| 2022-03-31 | $299 |
| 2021-12-31 | $260 |
| 2021-09-30 | $263 |
| 2021-06-30 | $260 |
| 2021-03-31 | $279 |
| 2020-12-31 | $228 |
| 2020-09-30 | $232 |
| 2020-06-30 | $40 |
| 2020-03-31 | $221 |
| 2019-12-31 | $245 |
| 2019-09-30 | $234 |
| 2019-06-30 | $211 |
| 2019-03-31 | $213 |
| 2018-12-31 | $195 |
| 2018-09-30 | $159 |
| 2018-06-30 | $193 |
| 2018-03-31 | $198 |
| 2017-12-31 | $44 |
| 2017-09-30 | $262 |
| 2017-06-30 | $258 |
| 2017-03-31 | $239 |
| 2016-12-31 | $258 |
| 2016-09-30 | $243 |
| 2016-06-30 | $223 |
| 2016-03-31 | $217 |
| 2015-12-31 | $241 |
| 2015-09-30 | $232 |
| 2015-06-30 | $222 |
| 2015-03-31 | $199 |
| 2014-12-31 | $243 |
| 2014-09-30 | $213 |
| 2014-06-30 | $218 |
| 2014-03-31 | $193 |
| 2013-12-31 | $219 |
| 2013-09-30 | $192 |
| 2013-06-30 | $208 |
| 2013-03-31 | $192 |
| 2012-12-31 | $215 |
| 2012-09-30 | $180 |
| 2012-06-30 | $186 |
| 2012-03-31 | $164 |
| 2011-12-31 | $193 |
| 2011-09-30 | $172 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical & Dental Supplies | $9.754B | $13.184B |
| Henry Schein Inc. is a leading distributor of health care products and services across the globe. The company serves office-based dental, medical and animal health practitioners, dental laboratories, government as well as institutional health care clinics and other alternate-care sites. Henry Schein's 3 businesses - Dental, Medical and Technology and Value-Added Services serve millions of customers worldwide. Henry Schein has completed the spinoff of its global Animal Health business. The global dental group serves office-based dental practitioners, dental laboratories, schools and other institutions. The global medical group serves office-based medical practitioners, ambulatory surgery centers, other alternate-care settings and other institutions. The global technology and value-added services group provides software, technology and other value-added services to health care practitioners. The technology group offerings include practice management software systems for dental and medical practitioners. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| McKesson (MCK) | United States | $104.880B | 22.04 |
| Cardinal Health (CAH) | United States | $54.109B | 20.66 |
| Becton Dickinson (BDX) | United States | $51.228B | 14.30 |
| West Pharmaceutical Services (WST) | United States | $25.687B | 42.94 |
| Straumann Holding AG (SAUHY) | Switzerland | $18.592B | 0.00 |
| Align Technology (ALGN) | United States | $10.528B | 16.28 |
| Cooper (COO) | United States | $10.130B | 11.56 |
| Merit Medical Systems (MMSI) | United States | $5.146B | 23.48 |
| DENTSPLY SIRONA (XRAY) | United States | $1.960B | 6.87 |
| CONMED (CNMD) | United States | $1.406B | 9.82 |
| STAAR Surgical (STAA) | United States | $1.125B | 35.07 |
| Pro-Dex (PDEX) | United States | $0.214B | 19.97 |
| Lifevantage (LFVN) | United States | $0.077B | 11.04 |